Stay Informed

Sign up for news & alerts

Already signed up?
Login here
What Can I Do?


Get Help
Need alcohol or drug help for yourself or someone else? GET HELP
Continuing Education
Free online courses for addiction counselors LEARN ONLINE
Resources
Resources
Find useful publications, online documents & more.


DrugScreening.org


 
Ore. Implements New Cold Medicine Regulations
November 16, 2004

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

New rules on pseudoephedrine-based cold tablets are now in effect in Oregon, which means people looking to buy certain cold medicines must show proper identification, the Associated Press reported Nov. 15.

The regulations were approved by the state Board of Pharmacy in October as a means of curbing Oregon's methamphetamine problem.

Under the new regulations, pharmacies are required to keep pseudoephedrine-based cold tablets behind the counter and sell them only to people with acceptable photo identification. In addition, grocery stores and convenience markets are banned from carrying certain cold remedies.

Methamphetamine is involved in 85 percent of the state's property and identity-theft crimes. Oregon also treats more people for methamphetamin addiction per capita than any other state in the nation.

COMMENTS ON THIS ARTICLE:

Your Turn! Post a public comment (read guidelines):

Name:

Comment:
(limit 200
words)
Enter this word
(help):		 Change

GUIDELINES: 
To keep this feature useful for all, please:

  1. Keep it clean, courteous, and on-topic. Comments are meant for thoughtful discussion of the article published above.

  2. Do not post promotional links to organizations, products or services, or personal requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercially-motivated posts are prohibited. We reserve the right to remove comments not conforming to these guidelines. (Report a comment).

Have questions or feedback? Contact us.